Akebia Therapeutics
AKBA
AKBA
118 hedge funds and large institutions have $392M invested in Akebia Therapeutics in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
36% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 28
33% more funds holding
Funds holding: 89 → 118 (+29)
10.54% more ownership
Funds ownership: 53.63% → 64.17% (+11%)
Holders
118
Holding in Top 10
3
Calls
$1.99M
Puts
$863K
Top Buyers
| 1 | +$15.1M | |
| 2 | +$12M | |
| 3 | +$10.5M | |
| 4 |
Renaissance Technologies
New York
|
+$9.18M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$8.94M |
Top Sellers
| 1 | -$4.24M | |
| 2 | -$4.2M | |
| 3 | -$2.41M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.9M |
| 5 |
CFIC
City Financial Investment Company
London,
United Kingdom
|
-$1.74M |